Everett Harris & CO Abbott Laboratories Transaction History

Everett Harris & CO

  • $7.77 Billion
  • Q2 2024

A detailed history of Everett Harris & CO transactions in Abbott Laboratories stock. As of the latest transaction made, Everett Harris & CO holds 1,527,229 shares of ABT stock, worth $171 Million. This represents 2.04% of its overall portfolio holdings.

Number of Shares
1,527,229
Previous 1,530,964 0.24%
Holding current value
$171 Million
Previous $174 Million 8.8%
% of portfolio
2.04%
Previous 2.32%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024
SELL
$100.73 - $112.44 $376,226 - $419,963
-3,735 Reduced 0.24%
1,527,229 $159 Million
Q1 2024

Apr 19, 2024
SELL
$109.52 - $120.96 $1.58 Million - $1.74 Million
-14,392 Reduced 0.93%
1,530,964 $174 Million
Q4 2023

Jan 18, 2024
BUY
$90.19 - $110.4 $195,892 - $239,788
2,172 Added 0.14%
1,545,356 $170 Million
Q3 2023

Oct 23, 2023
SELL
$95.53 - $114.62 $1.18 Million - $1.41 Million
-12,317 Reduced 0.79%
1,543,184 $149 Million
Q2 2023

Jul 26, 2023
SELL
$100.78 - $112.29 $268,477 - $299,140
-2,664 Reduced 0.17%
1,555,501 $170 Million
Q1 2023

Apr 24, 2023
SELL
$96.86 - $114.01 $58,600 - $68,976
-605 Reduced 0.04%
1,558,165 $158 Million
Q4 2022

Jan 20, 2023
SELL
$95.06 - $111.52 $153,807 - $180,439
-1,618 Reduced 0.1%
1,558,770 $0
Q3 2022

Oct 21, 2022
BUY
$96.76 - $112.03 $298,020 - $345,052
3,080 Added 0.2%
1,560,388 $151 Million
Q2 2022

Jul 22, 2022
SELL
$102.07 - $123.37 $3.08 Million - $3.73 Million
-30,222 Reduced 1.9%
1,557,308 $169 Million
Q1 2022

Apr 22, 2022
SELL
$114.02 - $139.04 $1.88 Million - $2.29 Million
-16,472 Reduced 1.03%
1,587,530 $188 Million
Q4 2021

Feb 02, 2022
SELL
$115.53 - $141.46 $762,960 - $934,201
-6,604 Reduced 0.41%
1,604,002 $226 Million
Q3 2021

Nov 03, 2021
SELL
$116.66 - $129.06 $2.3 Million - $2.54 Million
-19,716 Reduced 1.21%
1,610,606 $190 Million
Q2 2021

Jul 29, 2021
SELL
$105.79 - $124.53 $218,562 - $257,278
-2,066 Reduced 0.13%
1,630,322 $189 Million
Q1 2021

May 13, 2021
SELL
$108.84 - $128.23 $1.55 Million - $1.82 Million
-14,215 Reduced 0.86%
1,632,388 $196 Million
Q4 2020

Feb 04, 2021
SELL
$105.0 - $114.42 $2.84 Million - $3.09 Million
-27,040 Reduced 1.62%
1,646,603 $180 Million
Q3 2020

Nov 03, 2020
SELL
$91.64 - $111.29 $620,586 - $753,655
-6,772 Reduced 0.4%
1,673,643 $182 Million
Q2 2020

Jul 29, 2020
SELL
$76.57 - $98.0 $421,134 - $539,000
-5,500 Reduced 0.33%
1,680,415 $154 Million
Q1 2020

Apr 29, 2020
BUY
$62.82 - $91.86 $4.56 Million - $6.67 Million
72,563 Added 4.5%
1,685,915 $133 Million
Q4 2019

Jan 27, 2020
SELL
$78.51 - $87.4 $453,316 - $504,647
-5,774 Reduced 0.36%
1,613,352 $140 Million
Q3 2019

Nov 06, 2019
SELL
$81.84 - $88.74 $1.31 Million - $1.42 Million
-15,974 Reduced 0.98%
1,619,126 $135 Million
Q2 2019

Aug 13, 2019
SELL
$72.88 - $85.0 $362,213 - $422,450
-4,970 Reduced 0.3%
1,635,100 $138 Million
Q1 2019

May 13, 2019
SELL
$66.22 - $80.06 $1.38 Million - $1.67 Million
-20,884 Reduced 1.26%
1,640,070 $131 Million
Q4 2018

Feb 13, 2019
SELL
$65.56 - $74.27 $709,293 - $803,527
-10,819 Reduced 0.65%
1,660,954 $120 Million
Q3 2018

Nov 14, 2018
BUY
$60.81 - $73.36 $163,457 - $197,191
2,688 Added 0.16%
1,671,773 $123 Million
Q2 2018

Jul 27, 2018
SELL
$57.57 - $63.54 $175,243 - $193,415
-3,044 Reduced 0.18%
1,669,085 $102 Million
Q1 2018

Apr 20, 2018
BUY
$56.27 - $63.62 $2.29 Million - $2.59 Million
40,711 Added 2.5%
1,672,129 $100 Million
Q4 2017

Feb 01, 2018
SELL
$53.68 - $57.47 $246,069 - $263,442
-4,584 Reduced 0.28%
1,631,418 $93.1 Million
Q3 2017

Oct 11, 2017
BUY
$48.06 - $53.64 $78.6 Million - $87.8 Million
1,636,002
1,636,002 $87.3 Million

Others Institutions Holding ABT

# of Institutions
3,138
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Everett Harris & CO Portfolio

Follow Everett Harris & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email